Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hopax Fine Chemicals Group is a global leader in the manufacture of high-purity biological buffers and specialty chemicals for the life sciences, diagnostics, and pharmaceutical industries. Founded in 1975 and headquartered in Taiwan, the company specializes in Good's buffers such as HEPES, TRIS, and MES, which are essential for maintaining pH stability in cell culture and bioprocessing. Beyond life sciences, Hopax operates divisions for paper chemicals and self-adhesive products, including the well-known Stick'n brand. The company maintains rigorous quality standards, including GMP-compliant manufacturing and ISO certifications, to support global biopharmaceutical production and research. With a strong international presence, Hopax provides critical raw materials to major biotech and diagnostic companies worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hopax Fine Chemicals Group.